Yi Peng Selected Research

2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside

11/2016

PPAR-γ is involved in the protective effect of 2,3,4',5-tetrahydroxystilbene-2-O-beta-D-glucoside against cardiac fibrosis in pressure-overloaded rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Peng Research Topics

Disease

38	Neoplasms (Cancer) 07/2022 - 05/2007
12	Infections 04/2022 - 02/2009
10	Osteoarthritis 11/2022 - 01/2018
10	Neoplasm Metastasis (Metastasis) 02/2022 - 12/2010
8	Anemia 01/2021 - 01/2009
8	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 01/2008
7	Inflammation (Inflammations) 01/2022 - 01/2016
6	Hypoxia (Hypoxemia) 01/2022 - 01/2015
6	Carcinogenesis 01/2022 - 05/2007
6	Chronic Kidney Failure (Chronic Renal Failure) 03/2021 - 11/2010
6	Fibrosis (Cirrhosis) 01/2020 - 11/2016
5	Necrosis 01/2022 - 10/2012
5	Myocardial Infarction 10/2020 - 01/2016
5	Atherosclerosis 09/2019 - 01/2017
5	Wounds and Injuries (Trauma) 01/2019 - 10/2012
5	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 12/2014
4	Pain (Aches) 04/2022 - 04/2005
4	COVID-19 01/2022 - 01/2021
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 05/2015
4	Breast Neoplasms (Breast Cancer) 01/2015 - 12/2010
4	Tuberculosis (Tuberculoses) 01/2013 - 04/2010
3	Cognitive Dysfunction 10/2022 - 05/2012
3	Sepsis (Septicemia) 10/2022 - 01/2022
3	Heart Failure 07/2022 - 01/2021
3	Nasopharyngeal Carcinoma 02/2022 - 08/2017
3	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2020
3	Hemorrhage 01/2022 - 01/2019
3	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 11/2019
3	Infarction (Infarctions) 03/2019 - 01/2016
2	Vascular Remodeling 07/2022 - 12/2018
2	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 01/2008
2	Dementia (Dementias) 01/2022 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2022
2	Periodontitis 01/2022 - 12/2020
2	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2021 - 10/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2018

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2007
9	Androgen Receptors (Androgen Receptor)IBA 01/2013 - 05/2007
8	Pharmaceutical PreparationsIBA 07/2022 - 04/2010
5	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 12/2010
5	Transcription Factors (Transcription Factor)IBA 05/2022 - 01/2008
5	Biological ProductsIBA 01/2021 - 06/2012
5	Protein Isoforms (Isoforms)IBA 01/2021 - 04/2005
5	AndrogensIBA 12/2010 - 04/2008
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2017
4	Messenger RNA (mRNA)IBA 02/2022 - 04/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2013
3	MetalsIBA 04/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 02/2022 - 12/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2019
3	EnzymesIBA 01/2022 - 03/2012
3	LuciferasesIBA 01/2022 - 01/2013
3	Phosphotransferases (Kinase)IBA 01/2022 - 09/2015
3	Hormones (Hormone)IBA 07/2021 - 12/2008
3	AntioxidantsIBA 01/2021 - 01/2019
3	AntigensIBA 01/2021 - 06/2013
3	Long Noncoding RNAIBA 01/2021 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2008
3	IronIBA 01/2021 - 01/2009
3	CalciumIBA 03/2020 - 05/2012
3	Therapeutic UsesIBA 01/2020 - 05/2012
3	Becaplermin (PDGF-BB)FDA Link 01/2020 - 01/2019
3	CholesterolIBA 09/2019 - 01/2018
3	Apolipoproteins E (ApoE)IBA 09/2019 - 01/2018
3	HematinicsIBA 01/2018 - 01/2009
3	Hemoglobins (Hemoglobin)IBA 11/2017 - 01/2009
3	Histones (Histone)IBA 01/2015 - 01/2009
3	Peptides (Polypeptides)IBA 12/2013 - 03/2012
2	Sirtuin 1IBA 10/2022 - 07/2018
2	Superoxide DismutaseIBA 07/2022 - 01/2019
2	Oxygen (Dioxygen)IBA 07/2022 - 05/2018
2	pro-brain natriuretic peptide (1-76)IBA 06/2022 - 01/2021
2	6-methyladenineIBA 02/2022 - 01/2020
2	N-methyladenosineIBA 02/2022 - 01/2020
2	CytokinesIBA 01/2022 - 01/2021
2	VaccinesIBA 01/2022 - 01/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2019
2	Neutralizing AntibodiesIBA 01/2022 - 01/2022
2	ORALIT (ORS)IBA 11/2021 - 09/2014
2	RNA Splicing FactorsIBA 01/2021 - 11/2020
2	Apoptosis Regulatory ProteinsIBA 10/2020 - 01/2020
2	InflammasomesIBA 07/2020 - 01/2020
2	LigandsIBA 01/2020 - 01/2008
2	GlucocorticoidsIBA 01/2020 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2018

Therapy/Procedure

12	Renal Dialysis (Hemodialysis) 01/2022 - 04/2011
12	Therapeutics 01/2022 - 12/2008
6	Prostheses and Implants (Prosthesis) 04/2022 - 01/2018
6	Replacement Arthroplasty 04/2022 - 01/2018
4	Knee Replacement Arthroplasty (Total Knee Replacement) 06/2022 - 01/2018
4	Transplantation 03/2019 - 11/2010
3	Arthroplasty 11/2022 - 06/2020
3	Catheters 01/2022 - 01/2021
3	Oral Administration 01/2022 - 04/2017
3	Aftercare (After-Treatment) 12/2020 - 01/2013
2	Drug Therapy (Chemotherapy) 07/2022 - 01/2022
2	Hemiarthroplasty 04/2022 - 12/2020
2	Peritoneal Dialysis 01/2021 - 01/2015
2	Radiotherapy 10/2020 - 05/2018